Ypsomed Ltd
The conference has been instigated and organised by ABCD. Sponsors* have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.
*A. Menarini Farmaceutica Internazionale ERL, AstraZeneca UK, Bayer Public Limited Company, Boehringer-Ingelheim and Lilly Alliance, Daiichi Sankyo UK, Medice UK Ltd, Novo Nordisk
With innovative, simple-to-use and reliable products as well as modern care concepts we contribute significantly to the success of a therapy and thereby enable people to enjoy the best possible quality of life. We are committed to offer diabetes patients a range of therapy solutions, from automated insulin delivery to pen needles. With the mylife Loop Program, Ypsomed plans to offer a modular insulin pump system that makes managing your diabetes therapy less intrusive. Whether using Dexcom G6 Continuous Glucose Monitoring (CGM) System data, automated insulin delivery or just the pump on its own without sensor data, you will be able to control your insulin pump therapy from your smartphone. The program brings control, convenience and discretion to the small and lightweight mylife YpsoPump insulin pump system.
